Definitive Healthcare annual free cash flow
2020
2021
2022
2023
2024
2025
Definitive Healthcare Free Cash Flow (FCF) History (DH)
Definitive Healthcare reported $37.1M in free cash flow for fiscal 2025, a decrease of 19.18% from the previous fiscal year, with a free cash flow margin of 15.34%.
View full Definitive Healthcare company overviewDefinitive Healthcare free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $37.1M | −$8.8M | −19.18% | +15.34% |
| 2024 | 2024-12-31 | $45.9M | $7.6M | +19.99% | +18.18% |
| 2023 | 2023-12-31 | $38.2M | $11.0M | +40.22% | +15.20% |
| 2022 | 2022-12-31 | $27.3M | $8.8M | +47.46% | +12.24% |
| 2021 | 2021-12-31 | $18.5M | −$3.3M | −15.31% | +11.12% |
| 2020 | 2020-12-31 | $21.8M | — | — | +18.44% |
Definitive Healthcare quarterly free cash flow
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.5M | $1.5M | +21.44% | +15.43% |
| Q1 2026 | 2026-03-31 | $8.4M | −$10.0M | −54.46% | +14.95% |
| Q4 2025 | 2025-12-31 | −$1.7M | $1.0M | — | −2.80% |
| Q3 2025 | 2025-09-30 | $13.4M | −$5.3M | −28.18% | +22.33% |
| Q2 2025 | 2025-06-30 | $7.0M | −$6.6M | −48.56% | +11.54% |
| Q1 2025 | 2025-03-31 | $18.4M | $2.0M | +12.48% | +31.02% |
| Q4 2024 | 2024-12-31 | −$2.8M | −$6.9M | — | −4.44% |
| Q3 2024 | 2024-09-30 | $18.7M | $9.5M | +103.28% | +29.77% |
| Q2 2024 | 2024-06-30 | $13.6M | $2.3M | +20.65% | +21.38% |
| Q1 2024 | 2024-03-31 | $16.3M | $2.7M | +19.85% | +25.71% |
| Q4 2023 | 2023-12-31 | $4.1M | $13.2M | — | +6.24% |
| Q3 2023 | 2023-09-30 | $9.2M | $375,000 | +4.26% | +14.06% |
| Q2 2023 | 2023-06-30 | $11.3M | −$3.4M | −23.14% | +18.53% |
| Q1 2023 | 2023-03-31 | $13.6M | $780,000 | +6.08% | +23.00% |
| Q4 2022 | 2022-12-31 | −$9.1M | −$12.2M | — | −15.00% |
| Q3 2022 | 2022-09-30 | $8.8M | $10.2M | — | +15.35% |
| Q2 2022 | 2022-06-30 | $14.7M | $7.7M | +108.96% | +26.95% |
| Q1 2022 | 2022-03-31 | $12.8M | $3.2M | +32.57% | +25.61% |
| Q4 2021 | 2021-12-31 | $3.1M | — | — | +6.80% |
| Q3 2021 | 2021-09-30 | −$1.4M | — | — | −3.22% |
| Q2 2021 | 2021-06-30 | $7.0M | — | — | +17.66% |
| Q1 2021 | 2021-03-31 | $9.7M | — | — | +26.22% |
Definitive Healthcare free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $21.8M to $37.1M, a compound annual growth rate of 11.17%. Definitive Healthcare's latest reported quarter, Q2 2026, generated $8.5M in free cash flow, an increase of 21.44% year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Definitive Healthcare filings at SEC.gov ↗